| Symbol | WALDW |
|---|---|
| Name | WALDENCAST PLC |
| Sector | CONSUMER DISCRETIONARY |
| Region | North America |
| Industry | Package Goods/Cosmetics |
| Address | 81 FULHAM ROAD, LONDON, SW3 6RD, United States |
| Telephone | +1 917 546-6828 |
| Fax | — |
| — | |
| Website | https://www.waldencast.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001840199 |
| Description | Waldencast PLC is a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. Additional info from NASDAQ: |
Director Souza Cristiano 🟢 acquired 335.0K shares of Waldencast plc (WALD) at $1.51 Transaction Date: Aug 28, 2026 | Filing ID: 000096
Read moreDirector Brousset Michel 🔴 sold 264.3K shares (1 derivative) of Waldencast plc (WALD) Transaction Date: Jul 30, 2026 | Filing ID: 000093
Read moreDirector Sebti Hind 🔴 sold 193.8K shares (1 derivative) of Waldencast plc (WALD) Transaction Date: Jul 30, 2026 | Filing ID: 000092
Read moreManfredi Manuel 🟡 adjusted position in 0 shares (1 derivative) of Waldencast plc (WALD) Transaction Date: Jul 30, 2026 | Filing ID: 000091
Read moreWaldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
Read moreNew Form SCHEDULE 13G/A - Waldencast plc <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0000950157-26-000740 <b>Size:</b> 7 KB
Read moreObagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Read moreObagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
Read moreObagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
Read more